av/united-therapeutics--big.svg

NASDAQ:UTHR

United Therapeutics Corporation

  • Stock

USD

Last Close

360.22

30/08 20:00

Market Cap

14.61B

Beta: 0.60

Volume Today

392.55K

Avg: 596.50K

PE Ratio

11.12

PFCF: 13.12

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
174.56M
-
340.10M
94.83%
651.60M
91.59%
713.70M
9.53%
417.90M
41.45%
589.20M
40.99%
-104.50M
117.74%
514.80M
592.63%
475.80M
7.58%
727.30M
52.86%
984.80M
35.40%
depreciation and amortization
31.26M
-
32.20M
3.01%
32.90M
2.17%
31.60M
3.95%
31M
1.90%
35.90M
15.81%
45.90M
27.86%
49.90M
8.71%
49.90M
0%
51.30M
2.81%
53.20M
3.70%
deferred income tax
-104.30M
-
-82.70M
20.71%
-168.10M
103.26%
-89.70M
46.64%
-71.70M
20.07%
3.60M
105.02%
stock based compensation
320.79M
-
190.10M
40.74%
280.30M
47.45%
12.10M
95.68%
73.50M
507.44%
-26.40M
135.92%
45.40M
271.97%
163.80M
260.79%
138.50M
15.45%
106.80M
22.89%
39.10M
63.39%
change in working capital
-22.42M
-
-56.70M
152.89%
-37.30M
34.22%
-46.20M
23.86%
-83.20M
80.09%
130.70M
257.09%
37.30M
71.46%
4.30M
88.47%
-48.80M
1,234.88%
-35.10M
28.07%
-97.80M
178.63%
accounts receivables
-10.03M
-
-35.70M
256.04%
-30.50M
14.57%
-21.70M
28.85%
-82.70M
281.11%
121.40M
246.80%
24.40M
79.90%
-6M
124.59%
-41.30M
588.33%
-21.70M
47.46%
-58.50M
169.59%
inventory
-12.39M
-
-21M
69.44%
-6.80M
67.62%
-24.50M
260.29%
-500K
97.96%
9.30M
1,960.00%
12.90M
38.71%
10.30M
20.16%
-7.50M
172.82%
-13.40M
78.67%
-13.60M
1.49%
accounts payables
-16.30M
-
-16.80M
3.07%
112.90M
772.02%
150.60M
33.39%
57.10M
62.08%
other working capital
16.30M
-
16.80M
3.07%
-112.90M
772.02%
-150.60M
33.39%
-82.80M
45.02%
other non cash items
219.45M
-
-17M
107.75%
-301.70M
1,674.71%
-101.70M
66.29%
25.30M
124.88%
153.30M
505.93%
-148M
196.54%
191.00M
229.05%
72.50M
62.04%
23.90M
67.03%
-4.90M
120.50%
net cash provided by operating activities
425.27M
-
355.30M
16.45%
382.80M
7.74%
643.60M
68.13%
474.20M
26.32%
778.40M
64.15%
-206.60M
126.54%
755.70M
465.78%
598.20M
20.84%
802.50M
34.15%
978M
21.87%
investments in property plant and equipment
-31.91M
-
-47.40M
48.54%
-49.80M
5.06%
-38M
23.69%
-86.30M
127.11%
-184.40M
113.67%
-83.70M
54.61%
-59.30M
29.15%
-120.80M
103.71%
-138.80M
14.90%
-230.40M
65.99%
acquisitions net
-20.50M
-
681.60M
3,424.88%
366.10M
46.29%
7.10M
98.06%
-89.20M
1,356.34%
purchases of investments
-1.28B
-
-2.31B
80.45%
-1.90B
17.91%
-1.71B
9.85%
-2.51B
47.16%
sales maturities of investments
1.04B
-
1.63B
56.42%
1.53B
6.02%
1.03B
32.95%
2.14B
108.46%
other investing activites
-263.06M
-
385.90M
246.69%
553.40M
43.41%
86.30M
84.41%
-749.30M
968.25%
-636.20M
15.09%
8M
101.26%
-679.20M
8,590%
-366.10M
46.10%
3.50M
100.96%
-23M
757.14%
net cash used for investing activites
-294.97M
-
338.50M
214.76%
503.60M
48.77%
48.30M
90.41%
-835.60M
1,830.02%
-820.60M
1.80%
-335.40M
59.13%
-738.50M
120.18%
-486.90M
34.07%
-811.50M
66.67%
-719.60M
11.32%
debt repayment
-1.32M
-
-177.80M
13,369.70%
-133.20M
25.08%
-8.80M
93.39%
-250M
-
-200M
20%
-50M
75%
-800M
-
-100M
87.50%
common stock issued
14M
-
38.50M
175%
55.60M
44.42%
94.30M
69.60%
6.60M
93.00%
common stock repurchased
-42.44M
-
-483.10M
1,038.34%
-394.50M
18.34%
-500M
26.74%
-250M
50%
-2.10M
-
-3.70M
76.19%
-10.80M
191.89%
-11.40M
5.56%
-13.80M
21.05%
dividends paid
-14M
-
-38.50M
175%
-94.30M
-
-98M
3.92%
other financing activites
-5.12M
-
-576.60M
11,172.73%
-447M
22.48%
-497.70M
11.34%
43.30M
108.70%
256.30M
491.92%
813.30M
217.32%
36.80M
95.48%
886.80M
-
193.30M
78.20%
net cash used provided by financing activities
-5.12M
-
-576.60M
11,172.73%
-447M
22.48%
-497.70M
11.34%
43.30M
108.70%
6.30M
85.45%
611.20M
9,601.59%
-16.90M
102.77%
44.80M
365.09%
75.40M
68.30%
-11.90M
115.78%
effect of forex changes on cash
-319K
-
-3.75M
1,075.55%
-5.30M
41.23%
-3M
43.35%
200K
106.67%
net change in cash
124.86M
-
113.44M
9.15%
434.10M
282.67%
191.20M
55.95%
-317.90M
266.27%
-35.90M
88.71%
69.20M
292.76%
300K
99.57%
156.10M
51,933.33%
66.40M
57.46%
246.50M
271.23%
cash at beginning of period
154.03M
-
284.26M
84.55%
397.70M
39.91%
831.80M
109.15%
1.02B
22.99%
705.10M
31.08%
669.20M
5.09%
738.40M
10.34%
738.70M
0.04%
894.80M
21.13%
961.20M
7.42%
cash at end of period
278.89M
-
397.70M
42.60%
831.80M
109.15%
1.02B
22.99%
705.10M
31.08%
669.20M
5.09%
738.40M
10.34%
738.70M
0.04%
894.80M
21.13%
961.20M
7.42%
1.21B
25.65%
operating cash flow
425.27M
-
355.26M
16.46%
382.76M
7.74%
643.60M
68.15%
474.20M
26.32%
778.40M
64.15%
-206.60M
126.54%
755.70M
465.78%
598.20M
20.84%
802.50M
34.15%
978M
21.87%
capital expenditure
-31.91M
-
-47.44M
48.66%
-49.79M
4.96%
-43.20M
13.24%
-86.30M
99.77%
-184.40M
113.67%
-83.70M
54.61%
-59.30M
29.15%
-120.80M
103.71%
-138.80M
14.90%
-230.40M
65.99%
free cash flow
393.36M
-
307.82M
21.75%
332.97M
8.17%
600.40M
80.32%
387.90M
35.39%
594M
53.13%
-290.30M
148.87%
696.40M
339.89%
477.40M
31.45%
663.70M
39.02%
747.60M
12.64%

All numbers in USD (except ratios and percentages)